The focus in Specialty Care is on rare diseases and niche indications, and the products aim to make a significant difference for people with rare diseases.
The Specialty Care business unit was formed during 2017 by merging Sobi operations in Partner Products, Genetics & Metabolism and Inflammation.
We are actively seeking new products for our Specialty Care portfolio, to enhance efficiency and improve our ability to service the evolving needs of people with rare diseases. We are also working to attain more extensive product rights through several external opportunities.
Our Specialty Care unit has its own distribution networks across Europe, the Middle East, North Africa and North America which it uses to sell both proprietary and other products.